Sort   by:  
 Page size 
UnknownPrecision Breast Cancer Medicine: Early Stage Triple Negative Breast Cancer-A Review of Molecular Characterisation, Therapeutic Targets and Future Trends.
Not available
S-EPMC9393396 | biostudies-literature
UnknownA HER2-specific Modified Fc Fragment (Fcab) Induces Antitumor Effects Through Degradation of HER2 and Apoptosis.
Not available
S-EPMC4817942 | biostudies-literature
UnknownPhysical activity, diet and BMI in children aged 6-8 years: a cross-sectional analysis.
Not available
S-EPMC4054632 | biostudies-literature
UnknownThe PARTNER trial of neoadjuvant olaparib with chemotherapy in triple-negative breast cancer.
Not available
S-EPMC11136660 | biostudies-literature
UnknownNeoadjuvant PARP inhibitor scheduling in BRCA1 and BRCA2 related breast cancer: PARTNER, a randomized phase II/III trial.
Not available
S-EPMC12075821 | biostudies-literature
UnknownDimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC10831058 | biostudies-literature
UnknownTocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8084355 | biostudies-literature
UnknownCasirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8830904 | biostudies-literature
UnknownMetformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol.
Not available
S-EPMC12303861 | biostudies-literature
UnknownAspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8598213 | biostudies-literature
Sort   by:  
 Page size